PUBLISHER: IMARC | PRODUCT CODE: 1468163
PUBLISHER: IMARC | PRODUCT CODE: 1468163
The global IVF devices and consumables market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.7% during 2024-2032.
In vitro fertilization (IVF) is an assisted reproductive technology (ART) that helps with fertility, prevents genetic problems, and assists in the conception of a child. It comprises several medicines and surgical procedures for ovulation, egg retrieval, insemination and fertilization, and embryo culture and transfer. It also helps in achieving a successful pregnancy and healthy baby in women with blocked or damaged fallopian tubes. In addition, it aids in male infertility problems by using intra-cytoplasmic sperm injection (ICSI) for conceiving. At present, there is a rise in the utilization of IVF devices and consumables, such as instruments, accessories and disposable, and reagents and media, on account of the increasing rate of infertility across the globe.
The rising awareness among the masses about the benefits of using IVF devices and consumables for a successful pregnancy represents one of the key factors propelling the market growth. Besides this, there is an increase in the number of delayed pregnancies worldwide. This, along with the burgeoning healthcare industry, is contributing to the growth of the market. Moreover, the rising number of gamete donations around the world to help intended parents have a child is offering lucrative growth opportunities to industry investors. In addition, governments of several countries are extensively investing in healthcare infrastructures, which is positively influencing the market. Apart from this, key market players are financing research and development (R&D) activities for improving embryo culture and cryopreservation and in vitro maturation. They are also focusing on several marketing strategies to increase their customer base. Additionally, the integration of artificial intelligence (AI) in IVF for the identification of an embryo is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global IVF devices and consumables market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology and end user.
Instruments
Sperm Separation Systems
Cryosystems
Incubators
Imaging Systems
Ovum Aspiration Pumps
Cabinets
Micromanipulators
Others
Accessories and Disposables
Reagents and Media
Cryopreservation Media
Semen Processing Media
Ovum Processing Media
Embryo Culture Media
Fresh Embryo IVF
Frozen Embryo IVF
Donor Egg IVF
Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Coopersurgical Inc. (The Cooper Companies Inc), Esco Medical, FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation), Genea Biomedx, Hamilton Thorne Ltd., INVO Bioscience, Memmert GmbH + Co.KG, Merck KGaA, Nidacon International AB, Rocket Medical Plc, Thermo Fisher Scientific and Vitrolife.